Russian clinical practice guidelines for the management of c1 clinical class of chronic venous disorders (reticular veins and telangiectasias)-Reference-Cited by-同舟云学术

Russian clinical practice guidelines for the management of c1 clinical class of chronic venous disorders (reticular veins and telangiectasias)

Published:2021-01-16 Issue:3-4 Volume: Page:140-206
ISSN:2658-3542
Container-title:Нospital-replacing technologies:Ambulatory surgery
language:
Short-container-title:Ambulatornaya khirurgiya

Author:

Bogachev V. Yu.¹^ORCID,Rosukhovski D. A.²^ORCID,Borsuk D. A.³^ORCID,Shonov O. A.⁴,Manjikian H. P.⁵^ORCID,Lobastov K. V.⁶^ORCID,Burleva E. P.⁷^ORCID,Belentsov S. M.⁸^ORCID,Sapelkin S. V.⁹^ORCID,Fokin A. A.¹⁰^ORCID,Dvornikov A. S.⁶^ORCID,Pryadko S. I.¹¹^ORCID,Guzhkov O. N.¹²,Bredikhin R. A.¹³^ORCID,Barinov V. E.¹⁴,Soroka V. V.¹⁵,Larin S. I.¹⁶,Berezhnoi E. Y.¹⁷,Semenov A. Yu.¹⁸^ORCID,Raskin V. V.¹⁸^ORCID,Albitskii A. V.¹⁹,Arkadan N. R.²⁰,Belyanina E. O.²¹,Boldin B. V.⁶^ORCID,Glagoleva E. N.²²,Denisov V. E.²³,Dzenin O. V.²⁰^ORCID,Doronin I. V.²⁴,Ivanov O. O.²⁵^ORCID,Kaperiz K. A.²⁶^ORCID,Karev M. A.²⁷,Krylov A. V.²⁸,Krylov A. Yu.²⁹^ORCID,Letunovsky E. A.³⁰,Lobanov V. N.²⁰,Martynov V. S.³¹,Morenko D. N.³²,Pirozhenko P. A.³³,Savinova Y. V.³⁴,Suvorov K. S.³⁵,Terekhov A. M.³⁶,Turkin P. Yu.⁶^ORCID,Khafizov A. R.³⁷,Chabbarov R. G.³⁸,Sharipov A. S.³⁹,Kornievich S. N.⁴⁰,Zokirkhonov S. D.⁴¹,Shaydakov E. V.⁴²^ORCID

Affiliation:

1. Pirogov Russian National Research Medical University; First Phlebological Center

2. Institute of Experimental Medicine

3. Clinic of Phlebology and laser Surgery “Vasculab”

4. Laser Center “Delete”

5. tate Clinical Hospital named after A.K. Eramishantseva of the Department of Health of Moscow

6. Pirogov Russian National Research Medical University

7. Ural State Medical University

8. Medical Center ”Angio Line”

9. Vishnevsky National Medical Research Center of Surgery

10. South Ural State Medical University

11. Bakulev National Medical Research Center of Cardiovascular Surgery

12. Clinical Hospital No. 9

13. Interregional Clinical Diagnostic Center

14. Clinical Hospital No. 1 (Volynskaya); Central State Medical Academy

15. Saint Petersburg Research Institute of Emergency Medicine n.a. I.I. Dzhanelidze

16. Larin Volgograd Phlebo Center; Larin Kalmykia Center of Phlebology and Proctology

17. “Fleboart” clinic

18. Medical Innovation Phlebology Center

19. Clinic “Medalie”

20. First Phlebological Center

21. Frau Clinic

22. Aesthetic clinic “ComeMode Medical”; Pavlov First Saint Petersburg State Medical University

23. Medical Center “Phlebolog”

24. Scandinavian Health Center

25. Clinic of Phlebology

26. National Medical Research Center for Preventive Medicine

27. International Medical Center Меdical On Group – Odincovo

28. Medical Center “Clinic Allergomed”; Pavlov First Saint Petersburg State Medical University

29. Sechenov University

30. Center for laser Surgery

31. Phlebology Center

32. Medical Center “Nadejda”

33. Clinic for the Treatment of Varicose Veins “PhleboCenter”

34. Center of Phlebology of Dr. Savinov

35. Polyclinic №2 of the Presidential Administration of Russian Federation

36. Medical clinic “SOVA”

37. Clinic of Modern Phlebology

38. Omega Clinic

39. Phlebology Centre “Phlebomed”

40. Minsk Regional Clinical Hospital

41. Clinic of Contemporary Phlebology “Phlebolife”

42. Petrozavodsk State University; Petrov National Medical Cancer Research Centre

Abstract

Recently collated scientific data on the management of C1 clinical class of chronic venous disorders; wide prevalence of the disease and high variability amongst medical practitioners in relation to managing this category of patients and absence of any regulatory documents has prompted the development of clinical guidelines for the treatment of patients with reticular varicose veins and telangiectasias of the lower extremities and various parts of the body. These guidelines have been developed by a self-regulated organization Association “The National College of Phlebology”. The purpose of the de novo guidelines is to systematize the existing evidence and offer minimal standards of care for chronic venous disorders in C1 patients.

Publisher

Remedium, Ltd.

Reference318 articles.

1. Bogachev V.Yu. Sclerotherapy. Step by step. Telangiectasia. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2019;(1–2):52–58. (In Russ.) doi: 10.21518/1995-1477-2019-1-2-52-58.

2. Bogachev V.Yu., Boldin B.V., Lobanov V.N., Arkadan N.R., Ermak M.Yu. Adjuvant phlebotrophic therapy and its effect on anti-inflammatory response after sclerotherapy. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. 2016;22(4):90–95. (In Russ.) Available at: http://angiologia.ru/journals/angiolsurgery/2016/4/13.php.

3. Bogachev V.Yu., Boldin B.V., Turkin P.Yu. Detralex-phlebosclerosing treatment. results of the national multicenter follow up programme Vein Act Prolonged-C1. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. 2018;24(1):102–106. (In Russ.) Available at: http://www.angiolsurgery.org/en/magazine/2018/1/12.htm.

4. Bogachev V.Iu., Boldin B.V., Turkin P.Iu., Lobanov V.N. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. doi: 10.33529/ANGIO2019405.

5. Bogachev V.Yu., Grusha YA.O. The first experience with sclerotherapy of superficial periorbital veins. Flebologiya. 2010;4(2):17–22. (In Russ.) Available at: https://mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023/annotation.